[
  {
    "ts": "2025-10-10T21:37:42+00:00",
    "headline": "Equities Slide After Trump's China Tariffs Threat; Nasdaq Posts Worst Day Since April",
    "summary": "US equities plummeted Friday after President Donald Trump threatened China with steep tariff increas",
    "url": "https://finance.yahoo.com/news/equities-slide-trump-apos-china-213742084.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "edc49961-3c7a-3f05-8c53-ef802c398ca9",
      "content": {
        "id": "edc49961-3c7a-3f05-8c53-ef802c398ca9",
        "contentType": "STORY",
        "title": "Equities Slide After Trump's China Tariffs Threat; Nasdaq Posts Worst Day Since April",
        "description": "",
        "summary": "US equities plummeted Friday after President Donald Trump threatened China with steep tariff increas",
        "pubDate": "2025-10-10T21:37:42Z",
        "displayTime": "2025-10-10T21:37:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "stock trading floor NYSE market wall street  - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IeAizqJZBy9vwDXxekAvFA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OyOVBGCbqGk3V7zjfLwvvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-slide-trump-apos-china-213742084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-slide-trump-apos-china-213742084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T19:38:10+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Late Afternoon",
    "summary": "Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "477b3b96-6b85-3256-abef-fd665d28c064",
      "content": {
        "id": "477b3b96-6b85-3256-abef-fd665d28c064",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Late Afternoon",
        "description": "",
        "summary": "Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t",
        "pubDate": "2025-10-10T19:38:10Z",
        "displayTime": "2025-10-10T19:38:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "PTGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T18:40:10+00:00",
    "headline": "Equities, Oil Slump Intraday After Trump's China Tariffs Threat",
    "summary": "US benchmark equity indexes and oil prices tumbled intraday after President Donald Trump threatened",
    "url": "https://finance.yahoo.com/news/equities-oil-slump-intraday-trump-184010810.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "280dc58d-8ac1-341d-9939-2a5a596c4017",
      "content": {
        "id": "280dc58d-8ac1-341d-9939-2a5a596c4017",
        "contentType": "STORY",
        "title": "Equities, Oil Slump Intraday After Trump's China Tariffs Threat",
        "description": "",
        "summary": "US benchmark equity indexes and oil prices tumbled intraday after President Donald Trump threatened",
        "pubDate": "2025-10-10T18:40:10Z",
        "displayTime": "2025-10-10T18:40:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a",
          "originalWidth": 1024,
          "originalHeight": 768,
          "caption": "Stocks_Chart market equity trading wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0eWqzzTTIs4ZCQG0VOzLjA--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 1024,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/woUn3cfJYPXMhxA4_4CCeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-oil-slump-intraday-trump-184010810.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-oil-slump-intraday-trump-184010810.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "MP"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T18:07:36+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Friday Afternoon",
    "summary": "Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "a7561ee0-e53d-3718-94c5-04fe3bd8b0dd",
      "content": {
        "id": "a7561ee0-e53d-3718-94c5-04fe3bd8b0dd",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Friday Afternoon",
        "description": "",
        "summary": "Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care",
        "pubDate": "2025-10-10T18:07:36Z",
        "displayTime": "2025-10-10T18:07:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "USNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T17:28:03+00:00",
    "headline": "BMS expands CAR-T portfolio with $1.5bn Orbital buyout",
    "summary": "BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.",
    "url": "https://www.pharmaceutical-technology.com/news/bms-expands-car-t-portfolio-with-1-5bn-orbital-buyout/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "72fe7e6d-de66-3774-908b-33c99192b415",
      "content": {
        "id": "72fe7e6d-de66-3774-908b-33c99192b415",
        "contentType": "STORY",
        "title": "BMS expands CAR-T portfolio with $1.5bn Orbital buyout",
        "description": "",
        "summary": "BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.",
        "pubDate": "2025-10-10T17:28:03Z",
        "displayTime": "2025-10-10T17:28:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/f6c73e3b956bd57618c05550c3be973e",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/znqDhsgyE5ZBBD3zCKCAig--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/f6c73e3b956bd57618c05550c3be973e.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jlbu_Sx6JQ89eg0hDjnh2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/f6c73e3b956bd57618c05550c3be973e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/bms-expands-car-t-portfolio-with-1-5bn-orbital-buyout/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bms-expands-car-t-portfolio-172803335.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T16:19:00+00:00",
    "headline": "Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.",
    "summary": "The recent cavalcade of biotech deals continued Friday morning, when  Bristol Myers Squibb  said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech designing RNA-based medicines.  Its lead program, a potential treatment for autoimmune conditions called OTX-201, isn’t expected to enter human trials until next year.  The Orbital deal is Bristol’s largest since February 2024, when it closed a $4.1 billion acquisition of RayzeBio, a cancer-focused biotech.",
    "url": "https://www.barrons.com/articles/bristol-myers-squibb-orbital-therapeutics-9cbc5536?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9d415ae-bc30-3141-a6cb-2286f58343a3",
      "content": {
        "id": "e9d415ae-bc30-3141-a6cb-2286f58343a3",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.",
        "description": "",
        "summary": "The recent cavalcade of biotech deals continued Friday morning, when  Bristol Myers Squibb  said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech designing RNA-based medicines.  Its lead program, a potential treatment for autoimmune conditions called OTX-201, isn’t expected to enter human trials until next year.  The Orbital deal is Bristol’s largest since February 2024, when it closed a $4.1 billion acquisition of RayzeBio, a cancer-focused biotech.",
        "pubDate": "2025-10-10T16:19:00Z",
        "displayTime": "2025-10-10T16:19:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e9d415ae-bc30-3141-a6cb-2286f58343a3/bristol-myers-squibb-buys.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bf402q.1QSge2in2qsVa4w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9_PIBaIStwamvAA7QXT2sQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/bristol-myers-squibb-orbital-therapeutics-9cbc5536?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "AKRO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:57:00+00:00",
    "headline": "Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?",
    "summary": "MRK's Keytruda remains its dominant growth engine and is expected to have boosted its top line in the third quarter.",
    "url": "https://finance.yahoo.com/news/keytruda-continue-aid-mercks-top-155700998.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "80d09114-29d4-396e-9252-d77465a9638a",
      "content": {
        "id": "80d09114-29d4-396e-9252-d77465a9638a",
        "contentType": "STORY",
        "title": "Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?",
        "description": "",
        "summary": "MRK's Keytruda remains its dominant growth engine and is expected to have boosted its top line in the third quarter.",
        "pubDate": "2025-10-10T15:57:00Z",
        "displayTime": "2025-10-10T15:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EfDoN3QVRYGCfRDweFAACw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwDxubmjtiCRyiYBqVh9AQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/keytruda-continue-aid-mercks-top-155700998.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/keytruda-continue-aid-mercks-top-155700998.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T13:00:03+00:00",
    "headline": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-130003764.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a453cdbc-a53d-368d-8ca7-4d19c455ffcf",
      "content": {
        "id": "a453cdbc-a53d-368d-8ca7-4d19c455ffcf",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2025-10-10T13:00:03Z",
        "displayTime": "2025-10-10T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a",
          "originalWidth": 900,
          "originalHeight": 476,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5btkEdScc6bMd.LwAmujVg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 900,
              "height": 476,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSL6wqVlNgtKuHixyahWwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-130003764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-130003764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T12:55:30+00:00",
    "headline": "Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal",
    "summary": "Bristol-Myers Squibb (BMY) on Friday agreed to acquire privately-held ribonucleic acid medication ma",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-acquire-orbital-125530568.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "38bf6767-dcad-3911-a18c-b3f533532c15",
      "content": {
        "id": "38bf6767-dcad-3911-a18c-b3f533532c15",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal",
        "description": "",
        "summary": "Bristol-Myers Squibb (BMY) on Friday agreed to acquire privately-held ribonucleic acid medication ma",
        "pubDate": "2025-10-10T12:55:30Z",
        "displayTime": "2025-10-10T12:55:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/c214c675cb7e61beb54d67e6e3a79246",
          "originalWidth": 1000,
          "originalHeight": 678,
          "caption": "bmy - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lFNMViWQDwIQ6Dh07ZKfAw--~B/aD02Nzg7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/c214c675cb7e61beb54d67e6e3a79246.cf.webp",
              "width": 1000,
              "height": 678,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/meCDd9DyjGvgZSXcDxS2Hg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/c214c675cb7e61beb54d67e6e3a79246.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-acquire-orbital-125530568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-acquire-orbital-125530568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T12:03:05+00:00",
    "headline": "Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak",
    "summary": "The acquisition of the well-funded startup is the fourth this year involving companies with technologies that can genetically modify immune cells inside the body.",
    "url": "https://www.biopharmadive.com/news/bristol-myers-acquire-orbital-in-vivo-cell-therapy/802573/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "d7a62c20-e340-379d-a402-e476f2b8bc05",
      "content": {
        "id": "d7a62c20-e340-379d-a402-e476f2b8bc05",
        "contentType": "STORY",
        "title": "Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak",
        "description": "",
        "summary": "The acquisition of the well-funded startup is the fourth this year involving companies with technologies that can genetically modify immune cells inside the body.",
        "pubDate": "2025-10-10T12:03:05Z",
        "displayTime": "2025-10-10T12:03:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e78db2d69b1b3a516e232721008edcb9",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "B cells, like those pictured above, malfunction in autoimmune diseases and are the target of a number of CAR-T therapies in clinical testing.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dey6go5o80C.SIn3TMdZGQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e78db2d69b1b3a516e232721008edcb9.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Js.B8NPr5oRMMV171toVQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e78db2d69b1b3a516e232721008edcb9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/bristol-myers-acquire-orbital-in-vivo-cell-therapy/802573/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-1-5b-orbital-buyout-120305716.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T11:00:00+00:00",
    "headline": "Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives",
    "summary": "BMS and NCPA to address cardiovascular disease and enhance patient care coordination with specialized training in rural Alabama, Arkansas, Kentucky, Louisiana, Mississippi, and Missouri pharmacies Originally published on NCPA.org NORTHAMPTON, MA / ...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-national-community-110000535.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "790c52df-64b1-3375-8d28-c95b205d614b",
      "content": {
        "id": "790c52df-64b1-3375-8d28-c95b205d614b",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives",
        "description": "",
        "summary": "BMS and NCPA to address cardiovascular disease and enhance patient care coordination with specialized training in rural Alabama, Arkansas, Kentucky, Louisiana, Mississippi, and Missouri pharmacies Originally published on NCPA.org NORTHAMPTON, MA / ...",
        "pubDate": "2025-10-10T11:00:00Z",
        "displayTime": "2025-10-10T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-national-community-110000535.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-national-community-110000535.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T10:59:00+00:00",
    "headline": "Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics",
    "summary": "PRINCETON, N.J. & CAMBRIDGE, Mass., October 10, 2025--Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-strengthens-diversifies-105900890.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "31bdee1b-2ba2-3813-b7cf-382c2a940a83",
      "content": {
        "id": "31bdee1b-2ba2-3813-b7cf-382c2a940a83",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics",
        "description": "",
        "summary": "PRINCETON, N.J. & CAMBRIDGE, Mass., October 10, 2025--Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics",
        "pubDate": "2025-10-10T10:59:00Z",
        "displayTime": "2025-10-10T10:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/552558a48cd377396fdd3830b04e3327",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BQKWqvryGGCLwu1xDfXtyw--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/552558a48cd377396fdd3830b04e3327.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vAG.gz_xDqF3vTc1xgrOJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/552558a48cd377396fdd3830b04e3327.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-strengthens-diversifies-105900890.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-strengthens-diversifies-105900890.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T10:45:00+00:00",
    "headline": "Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection",
    "summary": "PRINCETON, N.J., October 10, 2025--Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Campaign Spotlighting the Power of Support and Connection",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-tv-host-104500163.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ac03fb1a-43bd-3fc3-9ce9-a685169081d5",
      "content": {
        "id": "ac03fb1a-43bd-3fc3-9ce9-a685169081d5",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection",
        "description": "",
        "summary": "PRINCETON, N.J., October 10, 2025--Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Campaign Spotlighting the Power of Support and Connection",
        "pubDate": "2025-10-10T10:45:00Z",
        "displayTime": "2025-10-10T10:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/bbfaf0ea4609760ad87fdb1b5c3c8295",
          "originalWidth": 480,
          "originalHeight": 320,
          "caption": "Gail Simmons, culinary expert, TV host and author. Photo: Bristol Myers Squibb",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LVbxv79ytidBapMd1eOlKA--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bbfaf0ea4609760ad87fdb1b5c3c8295.cf.webp",
              "width": 480,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/novLiYARy8M2KiMQIqeQ1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bbfaf0ea4609760ad87fdb1b5c3c8295.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-tv-host-104500163.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-tv-host-104500163.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:47:25+00:00",
    "headline": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
    "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
    "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
      "content": {
        "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
        "contentType": "STORY",
        "title": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
        "description": "",
        "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
        "pubDate": "2025-10-10T15:47:25Z",
        "displayTime": "2025-10-10T15:47:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZC_4u8KKl6ge5b9LszTFog--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.cqdgPcBT28.iZJmhZaOKg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:47:25+00:00",
    "headline": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
    "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
    "url": "https://ca.finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725854.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "6c8b6a75-a122-3faf-b6b6-2e694c12e135",
      "content": {
        "id": "6c8b6a75-a122-3faf-b6b6-2e694c12e135",
        "contentType": "STORY",
        "title": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
        "description": "",
        "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
        "pubDate": "2025-10-10T15:47:25Z",
        "displayTime": "2025-10-10T15:47:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/8714f82637f325f9c89701464434eee3",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3jxEInh7Q9TH4pSFPfbJag--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/8714f82637f325f9c89701464434eee3.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OotD94sOAsDlWtJUzBixdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/8714f82637f325f9c89701464434eee3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725854.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725854.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]